Novo Nordisk positions
The Novo Nordisk business is based on a clear vision, a strong set of core values and a consistent corporate governance model.
As a natural consequence, we have formulated positions on issues of relevance to our business and our role as a global corporate citizen:
- Access to health
- Animal experimentation
- Climate change
- Clinical trials
- Counterfeit medicines
- Gene technology
- Human rights
- Intellectual property rights and patenting
- Use of non-human primates
- Stem cells
The positions presented express our views as well as the context and the background for the position.
Below, Novo Nordisk contact persons are named, from whom more information on each issue can be obtained.
Media representatives are kindly asked to contact our Media Relations Team.
| Position | Contacts |
| Access to health | Lene Andersen |
| Climate | Susanne Stormer |
| Animal experimentation | Mads Krogsgaard Thomsen |
| Gene technology | Steen Weber Jensen |
| Human rights | Lene Andersen |
| IPR and patenting | Lars Kellberg |
| Stem cells | Mads Krogsgaard Thomsen |
| Use of non-human primates | Mads Krogsgaard Thomsen |
| Counterfeit medicines | Lars Guldbæk Karlsen |
